Hyperbaric oxygen for idiopathic sudden hearing loss and tinnitus (Cochrane Review)
Record details
- Authors: Bennett MH, et al.
- Journal / source: Cochrane Database of Systematic Reviews (2012)
- Design: Systematic review
- Sample: 392 (7 RCTs)
- Primary endpoint: Hearing/tinnitus improvement
- Randomized: Yes · Sham/placebo-controlled: Yes · Independent of the manufacturer: Yes
What this research found
Studies small and methodologically poor; 'the significance of any improvement in tinnitus could not be assessed'; no benefit for chronic (>6-month) tinnitus; routine use cannot be justified.
Limitations and conflicts of interest
See the record summary above.
Funding / conflicts: Independent.
Primary sources
Used as evidence for
This is an original summary from the Tinnitus Evidence verified database, checked against the primary source — not a reproduction of the publisher's abstract.